Skip to main content
Premium Trial:

Request an Annual Quote

One Analyst Upgrades Waters Stock Behind Three Downgrades; Shares Remain Flat

NEW YORK, March 31 (GenomeWeb News) - An analyst at JP Morgan upgraded Waters' stock today while Stanford Research downgraded it, one day after two other analysts downgraded the stock after the company on Tuesday said first-quarter earnings and product sales will be lower than expected.


The upgrade from JP Morgan, the only upgrade to follow Waters' March 29 announcement, reclassified the stock as "overweight" from "neutral" today. Stanford Research took the stock down one notch from "buy" to "hold."


Analysts at Robert W. Baird, Merrill Lynch, and Lehman Brothers each lowered their evaluations of Waters' stock yesterday.


Shares in Waters remained flat in mid-afternoon trading today at $36.22, after tumbing $9.71, or 21 percent, Wednesday after the company revised its expected earnings.

On March 29, Waters revised its estimate of 2005 sales growth to between 3 and 4 percent from the 13- to 14-percent range it identified in a January conference call with investors. The company also revised its projected first-quarter per-share earnings from $.44 to between $.34 and $.37. In a statement, the firm said that the lowered earnings were the result of "weaker than expected sales growth."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.